SEC Form 4 · accession 0001209191-15-049837
Larimar Therapeutics, Inc. · LRMR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Avi Y. Goldberg
Director
Period of report
Jun 1, 2015
Accepted (ET)
Jun 3, 2015 · 7:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001374690
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 1, 2015 | S | 2,000 | $32.2262 | D | 61,734 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale of 2,000 shares of Common Stock by the Reporting Person was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- F2At the time of the Reporting Person's last ownership report, the Reporting Person was a partner at Greatpoint Ventures Fund I, LLC ("GPV") and reported as beneficial owned 345,642 shares of Common Stock owned by GPV. On December 29, 2014, GPV made a distribution of 115,880 shares of Common Stock to the Reporting Person upon the termination of the relationship between the Reporting Person and GPV. The reporting person no longer reports as beneficially owned any securities owned by GPV. On April 17, 2015, the Reporting Person transferred 52,146 shares pursuant to a court decree. The Reporting Person no longer reports as beneficially owned these transferred shares.